Search results
FDA issues warning to Cue Health over COVID-19 test By Investing.com
Investing.com· 2 days agoCue Health Inc. (NASDAQ:HLTH), a healthcare technology company, has received a warning letter from...
After FDA warning, Getinge trims sales of heart devices
Becker’s Hospital Review· 23 hours agoAfter the FDA instructed healthcare facilities to avoid using two Getinge heart devices because of quality and safety concerns, the company stopped promoting the products.
New Clozapine Data Suggest FDA Should Ease Restrictions
Medscape· 1 day agoThe risk for severe neutropenia with clozapine is minimal, suggesting that burdensome FDA-required hematologic monitoring should be relaxed, researchers said.
US FDA approves expanded use of Bristol's cancer cell therapy
Reuters via Yahoo Finance· 9 hours agoMay 15 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi to include the treatment of adults with ...
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 6 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
The Forces Weighing Against FDA Bans on Toxic Ingredients
Bloomberg· 20 hours agoGood morning, it’s Fiona in New York. The FDA has missed a deadline for a proposed ban on a...
FDA posts final guidance on remanufacturing medical devices
MedTech Dive via Yahoo Finance· 6 days agoNearly three years after publishing draft guidance, the FDA has changed the title and added a...
Earnings call: Liquidia Corporation eyes FDA nod for YUTREPIA By Investing.com
Investing.com· 1 day agoLiquidia Corporation (LQDA) reported its financial results for the first quarter of 2024 and...
FDA said it "never" inspected dental lab that made controversial AGGA device
CBS News· 3 days agoThe FDA never inspected Johns Dental Laboratories during more than a decade in which it made the...
Q1 2024 Acurx Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 hours agoHaving robust preclinical, clinical and manufacturing data to date, we submitted, in January, a formidable information package to the FDA, along with a request for an end ...